ArticleInternational journal of molecular sciences2026
Personalized Pathogenicity Assessment of
Ke Ye, Suai Zhang, Ping Xu, Xiaojing Song, Yuan Wang, Xiufeng Zhong
Abstract read
In one paragraphArticle in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
6 authors.
Ke YeState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou 510060, China.ORCID 0000-0002-9593-9007 Suai ZhangState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou 510060, China.
Ping XuState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou 510060, China.
Xiaojing SongState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou 510060, China.
Yuan WangState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou 510060, China.
Xiufeng ZhongState Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou 510060, China.
Funding
a Joint grant from Science & Technology Project of Guangzhou and Zhongshan Ophthalmic Center, Sun Yat-sen University 202201020312National Key Research and Development Program of the Ministry of Science and Technology 2017YFA0104101National Key Research and Development Program of the Ministry of Science and Technology 2023YFC2506100National Natural Science Foundation of China 81970842National Natural Science Foundation of China 82172957Science & Technology Project of Guangdong Province 2017B020230003the Fundamental Research funds of the State Key Laboratory of Ophthalmology N/AThe Science & Technology Project of Guangzhou 202102010288
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
cis-trans-IsomerasesInduced Pluripotent Stem CellsLeber Congenital AmaurosisMutationRetinal Pigment EpitheliumGene Therapy AgentsGenetic TherapyHEK293 CellsHumansRetinoid Isomerohydrolasecis-trans-IsomerasesRetinoid Isomerohydrolasegene therapyLeber’s congenital amaurosisretinal pigment epitheliumRPE65stem cellsvitamin A cycle
Identifiers
PMID42449920
PMCPMC13361107
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390